DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

72 hedge funds and large institutions have $391M invested in Dicerna Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
+22
Holders Change %
+44%
% of All Funds
1.65%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.18%
New
27
Increased
16
Reduced
16
Closed
5
Calls
$20K
Puts
$1.19M
Net Calls
-$1.17M
Net Calls Change
-$3.45M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$11.8M
2
Goldman Sachs
2
Goldman Sachs
New York
$7.54M
3
GTC
3
Ghost Tree Capital
New York
$9.08M
4
AG
4
Artal Group
Luxembourg
$4.06M
5
Millennium Management
5
Millennium Management
New York
$3.9M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$37.6M
2
6CM
2
683 Capital Management
New York
$1.2M
3
EMFAT
3
Emerald Mutual Fund Advisers Trust
Pennsylvania
$1.45M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$2.77M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$16.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$85.4M – – –
RI
2
RTW Investments
New York
$48.1M -$59.3K -6,200 -0.1%
EC
3
EcoR1 Capital
California
$45.5M -$689K -72,100 -1%
RCM
4
RA Capital Management
Massachusetts
$37.6M -$9.87M -1,032,024 -21%
CAM
5
Cormorant Asset Management
Massachusetts
$34.4M -$533K -55,715 -2%
Adage Capital Partners
6
Adage Capital Partners
Massachusetts
$16.5M -$2.39M -250,000 -13%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$16.3M – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$11.8M +$6.13M +640,827 +109%
BM
9
Bridger Management
New York
$11.7M +$3.07M +320,822 +35%
CCM
10
Camber Capital Management
Massachusetts
$9.56M – – –
GTC
11
Ghost Tree Capital
New York
$9.08M +$4.3M +450,000 +90%
Goldman Sachs
12
Goldman Sachs
New York
$7.54M +$5.68M +594,406 +306%
UBS Group
13
UBS Group
Switzerland
$5.75M -$98.5K -10,305 -2%
PAI
14
Palo Alto Investors
California
$4.79M – – –
First Manhattan
15
First Manhattan
New York
$4.09M – – –
AG
16
Artal Group
Luxembourg
$4.06M +$4.06M +425,000 New
Millennium Management
17
Millennium Management
New York
$3.9M +$3.26M +340,623 +509%
Renaissance Technologies
18
Renaissance Technologies
New York
$2.77M -$2.59M -270,900 -48%
BlackRock
19
BlackRock
New York
$2.65M +$1.53M +160,172 +137%
EU
20
Emory University
Georgia
$2.36M +$2.36M +246,411 New
OFM
21
Omega Fund Management
Massachusetts
$2.14M – – –
OAM
22
Oxford Asset Management
United Kingdom
$1.81M +$1.3M +136,132 +256%
Citadel Advisors
23
Citadel Advisors
Florida
$1.63M +$1.63M +170,741 New
Geode Capital Management
24
Geode Capital Management
Massachusetts
$1.54M +$667K +69,840 +76%
EMFAT
25
Emerald Mutual Fund Advisers Trust
Pennsylvania
$1.45M -$4.01M -419,290 -73%
1
2 3 4